| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2020 | TECHNOLOGY COMMERCIALIZATION PARTNERS LLC | 7012 FOUNDERS DR | BIRMINGHAM | AL | 35242-2509 | SHELBY | USA | R41HL152921 | Chemical-based Nitric Oxide Gas-generating Drug Device for the Treatment of Pulmonary Hypertension | 000 | 1 | NIH | 10/12/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2020 | TECHNOLOGY COMMERCIALIZATION PARTNERS LLC | 7012 FOUNDERS DR | BIRMINGHAM | AL | 35242-2509 | SHELBY | USA | R43CA246883 | Targeted Exosome-Associated AAV-Mediated Gene Therapy to Eliminate Metastatic Neuroendocrine Cancers | 000 | 1 | NIH | 6/12/2023 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | TECHNOLOGY COMMERCIALIZATION PARTNERS LLC | 7012 FOUNDERS DR | BIRMINGHAM | AL | 35242-2509 | SHELBY | USA | R41OD027206 | A Portable Device for Accurate Mouse Tail Vein Injection | 000 | 1 | NIH | 8/22/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $708,363 ) |
| | 2020 | 2020 | TECHNOLOGY COMMERCIALIZATION PARTNERS LLC | 7012 FOUNDERS DR | BIRMINGHAM | AL | 35242-2509 | SHELBY | USA | R43CA246883 | Targeted Exosome-Associated AAV-Mediated Gene Therapy to Eliminate Metastatic Neuroendocrine Cancers | 000 | 1 | NIH | 6/17/2020 | $243,144 |
| | 2020 | 2020 | TECHNOLOGY COMMERCIALIZATION PARTNERS LLC | 7012 FOUNDERS DR | BIRMINGHAM | AL | 35242-2509 | SHELBY | USA | R41HL152921 | Chemical-based Nitric Oxide Gas-generating Drug Device for the Treatment of Pulmonary Hypertension | 000 | 1 | NIH | 8/10/2020 | $465,219 |
| | 2020 | 2019 | TECHNOLOGY COMMERCIALIZATION PARTNERS LLC | 7012 FOUNDERS DR | BIRMINGHAM | AL | 35242-2509 | SHELBY | USA | R41OD027206 | A Portable Device for Accurate Mouse Tail Vein Injection | 000 | 1 | NIH | 3/28/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $175,264 ) |
| | 2019 | 2019 | TECHNOLOGY COMMERCIALIZATION PARTNERS LLC | 7012 FOUNDERS DR | BIRMINGHAM | AL | 35242-2509 | SHELBY | USA | R41OD027206 | A Portable Device for Accurate Mouse Tail Vein Injection | 000 | 1 | NIH | 8/16/2019 | $175,264 |
|
|
